1.Dengue 2 virus induces molecular alteration in the coagulant and fibrinolytic pathways of human umbilical vein endothelial cells
Xiaolong TANG ; Shuyu CAI ; Zhenyou JIANG ; Lifan JIANG
Journal of Third Military Medical University 2003;0(08):-
Objective To study the changes of tissue plasminogen activator (t-PA), plasminogen activator inhibitor 1 (PAI-1), and soluble thrombomodulin (sTM) induced by dengue 2 virus (D 2V) infection of vascular endothelial cells. Methods The effects of D 2V infection on the production of t-PA, PAI-1, and sTM of human umbilical cord vein cells were studied. Results D 2V infection significantly induced the secretion of sTM and t-PA but showed no such effects on PAI-1 of human endothelial cells. Antibody against IL-6 inhibited D 2V-induced t-PA production of endothelial cells. A close correlation between serum levels of IL-6 and t-PA was found in dengue hemorrhagic fever (DHF) but not in dengue fever (DF) patients. Conclusion IL-6 can regulate D 2V-induced t-PA production of endothelial cells, suggesting that endothelial cells can be the target for D 2V infection and that D 2V-induced t-PA, TM, and IL-6 production of endothelial cells may contribute to the pathogenic development of dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS).
2.Practice and thinking of pre-hospital emergency support for the 2022 Beijing Winter Olympic Games
Hui LIU ; Lifan LI ; Jiang LIU ; Hongmei LIU ; Ting ZHONG ; Zhenjun XIANG ; Yilin ZHAO ; Xu WANG ; Qian WANG
Chinese Journal of Hospital Administration 2022;38(9):709-711
Under the leadership of the Beijing Winter Olympic Organizing Committee and the Beijing Municipal Health Commission, the Beijing Emergency Center, as the designated medical institution for the 2022 Beijing Winter Olympic Games, has completed the first aid support task of this Winter Olympic Games with other medical institutions. The author systematically analyzed the development of each link in the pre-hospital emergency support for the 2022 Beijing Winter Olympic Games, summarizes the key links of the entire Winter Olympics cycle, such as the construction of the organizational system, the formulation of support plans, and the training of support personnel, and analyzed the results of related work, so as to provide reference for the pre-hospital emergency support for China to host large-scale international events in the future.
3.Predictive value of fragmented QRS wave for prognosis in patients with acute no ST elevation myocardi‐al infarction/
Lifan CHEN ; Lei WU ; Ziping WU ; Teqi LI ; Han JIANG
Chinese Journal of cardiovascular Rehabilitation Medicine 2019;28(6):20-23
To explore predictive value of fragmented QRS wave (fQRS) for prognosis in patients with a‐cute no ST elevation myocardial infarction (NSTEMI).Methods : According to ECG measure result , 120 NSTEMI patients treated in our hospital from Jan 2015 to Feb 2017 were divided into fQRS group (n=73) and no fQRS group (n=47).Both groups received same treatment .General information and incidence of MACE during one‐year fol‐low‐up were compared between two groups .Results : There were no significant difference in heart rate ,percentage of dyslipidemia ,hypertension and diabetes mellitus between two groups ( P> 0. 05 all).Compared with no fQRS group ,there were significant reduction in left ventricular ejection fraction [(63. 81 ± 5.67)% vs.(52. 18 ± 5. 81)%, P=0. 001] , and significant rise in percentage of previous myocardial infarction (21.28% vs.39. 73%, P=0.035) and more than three coronary stenosis greater than or equal to 50%(36.17% vs.54.79%, P= 0.046) in fQRS group .Compared with no fQRS group ,incidence of MACE of fQRS group was higher (25. 53% vs.45.21%, P=0.030).Conclusion :Cardiac function of NSTEMI patients with fQRS is significantly poorer than that of patients without fQRS ,so patients with fQRS predicts their state of an illness is serious and prognosis is poor .
4.Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer.
Jie CHANG ; Ruirui YANG ; Lifan CHEN ; Zisheng FAN ; Jingyi ZHOU ; Hao GUO ; Yinghui ZHANG ; Yadan LIU ; Guizhen ZHOU ; Keke ZHANG ; Kaixian CHEN ; Hualiang JIANG ; Mingyue ZHENG ; Sulin ZHANG
Acta Pharmaceutica Sinica B 2022;12(5):2619-2622
Image 1.